These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7858159)

  • 1. Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
    Delacourte A
    Biomed Pharmacother; 1994; 48(7):287-95. PubMed ID: 7858159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
    Buée-Scherrer V; Buée L; Hof PR; Leveugle B; Gilles C; Loerzel AJ; Perl DP; Delacourte A
    Am J Pathol; 1995 Apr; 146(4):924-32. PubMed ID: 7717459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
    Sergeant N; David JP; Lefranc D; Vermersch P; Wattez A; Delacourte A
    FEBS Lett; 1997 Aug; 412(3):578-82. PubMed ID: 9276470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration and plasticity.
    Arendt T
    Int J Dev Neurosci; 2004 Nov; 22(7):507-14. PubMed ID: 15465280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.
    Harrington CR; Perry RH; Perry EK; Hurt J; McKeith IG; Roth M; Wischik CM
    Dementia; 1994; 5(5):215-28. PubMed ID: 7951676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
    Weaver CL; Espinoza M; Kress Y; Davies P
    Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.
    Delacourte A; Flament S; Dibe EM; Hublau P; Sablonnière B; Hémon B; Shérrer V; Défossez A
    Acta Neuropathol; 1990; 80(2):111-7. PubMed ID: 2117840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Trends Neurosci; 1993 Nov; 16(11):460-5. PubMed ID: 7507619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias.
    Delacourte A
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():75-9. PubMed ID: 10436346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
    Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
    FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
    Goedert M
    Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
    Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
    Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
    Delacourte A; David JP; Sergeant N; Buée L; Wattez A; Vermersch P; Ghozali F; Fallet-Bianco C; Pasquier F; Lebert F; Petit H; Di Menza C
    Neurology; 1999 Apr; 52(6):1158-65. PubMed ID: 10214737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.